An Abnormality of the Growth Hormone/Insulin-Like Growth Factor-I Axis in Women with Polycystic Ovary Syndrome

Ralph R. Kazer*, Terry G. Unterman, Roberta P. Glick

*Corresponding author for this work

Research output: Contribution to journalArticle

54 Scopus citations

Abstract

To investigate the GH/insulin-like growth factor-I (IGF-I) axis in women with polycystic ovary syndrome (PCO), we measured serum concentrations of GH over a 14-h period (0900–2300 h) in 10 women with this disorder using an ambulatory exfusion pump. The same study was carried out in 9 age- and weight-matched normal cycling women who served as controls. Mean (±se) serum GH concentrations over the 14-h period were markedly lower in the subjects with PCO (0.6 ± 0.2 vs. 1.8 ± 0.3 μg/L; P < 0.005). Eight of 10 subjects with PCO had mean serum GH concentrations below 1.2 μg/L, while only 1 of 9 control subjects had corresponding values below this concentration. In contrast, mean circulating serum concentrations of IGF-I were indistinguishable in the 2 groups. We conclude from these data that PCO is characterized by decreased serum GH concentrations in the face of normal serum IGF-I concentrations. The mechanisms underlying this alteration in the GH/IGF-I axis and its role in the pathogenesis of PCO remain to be clarified.

Original languageEnglish (US)
Pages (from-to)958-962
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume71
Issue number4
DOIs
StatePublished - Oct 1990

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'An Abnormality of the Growth Hormone/Insulin-Like Growth Factor-I Axis in Women with Polycystic Ovary Syndrome'. Together they form a unique fingerprint.

  • Cite this